Sepha to launch mobile blisterpacking technology
Total Processing and Packaging exhibition
Stand no: 5525
EZBII is a compact and easy-to-use table-top machine that has been developed in response to global demand from major pharmaceutical and clinical trial laboratories for blisterpacking solutions that are flexible, adaptable and capable of handling complex pack designs at minimal cost.
EZBII will enable labs requiring short runs of high quality blisterpacks to choose from a range of technical options and combine these with extensive standard features, creating a final product that is tailored to their exact commercial and production requirements. Options such as nitrogen purge, Teflon-coated forming plates, pressure boosters and batch coding enable blisterpacks to be produced from difficult to form materials, such as Aclar, while maintaining full traceability over drugs in clinical trials.
‘With fast set-up and minimal operator training required, EZBII offers pharmaceutical research and clinical trial companies a blisterpacking machine that combines the flexibility, technology and cost savings that they need in an increasingly competitive market,’ saidSepha product manager Phil Stevenson.
‘In a global industry where cost of ownership is vital, the ability to customise, tool and tailor the EZBII to exact customer specification means that the commercial and technology needs of our customers can be balanced.’
In recent years the company has become increasingly involved in developing more sophisticated and complex blisterpack designs such as those that incorporate different products, and packs where different doses have to be highlighted and separated. To support these evolving pack requirements Sepha offers a full blisterpack and tooling design service with EZBII, enabling customers to maximise the delivery options of their new products.
You may also like
Manufacturing
Decentralised manufacturing: how outsourcing is helping to bring the personalised medicine promise to reality
Read morePersonalised medicine represents a revolution in healthcare strategies. Combining traditional clinical information with genetic data delivers a highly targeted treatment to either a stratified patient cohort or individual patients based on specific tissues and gene therapies, as well as the DNA of the disease
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Manufacturing
Decentralised manufacturing: how outsourcing is helping to bring the personalised medicine promise to reality
Personalised medicine represents a revolution in healthcare strategies. Combining traditional clinical information with genetic data delivers a highly targeted treatment to either a stratified patient cohort or individual patients based on specific tissues and gene therapies, as well as the DNA of the disease